FAQ

It is not fully known how IUDs work. However, nowadays it is assumed that the most probable effect is that it disrupts the normal function of the male gametes (sperm), which become incapable of fertilizing the female egg. It is also assumed that copper ions influence the development of the egg so that fertilization doesn´t take place: IUDs are no longer considered a method of abortion.

Insertion is recommended during or shortly following menstruation. If pregnancy is excluded, EurimPharm IUDs may be inserted at any time of the cycle. Postpartum insertion should be postponed until six weeks after delivery, as this is associated with high rates of perforation and expulsion. There are no doubts against breast feeding at lying IUD.

The available experience indicates that, in general, drugs interfering with contraceptive efficacy of EurimPharm IUDs are highly unlikely. However, published reports appear to show diminished efficacy in the presence of long-term use of non-steroidal anti-inflammatory drugs (especially acetylsalicylic acid) and corticoids. Short-term use in the treatment of dysmenorrhoea with not-steroidal anti-inflammatory drugs does not appear to reduce contraceptive efficacy.

EurimPharm IUPs may not be used at:

• Malignant diseases of the genital tract
• Vaginal bleeding
• Pregnancy
• Past history of ectopic pregnancy or predisposing factors
• Infections of the genital tract
• Sexually transmitted diseases during the last 12 months (except bacterial vaginitis, repeated herpes infection, hepatitis B)
• Abortion with infection during the last 3 months, pelvic inflammatory disease (PID)
• Uterine malformations (congenital or acquired)
• Allergy to copper

MR Conditional

Non-clinical testing has demonstrated that the EurimPharm intrauterine devices are MR conditional. A patient with a EurimPharm intrauterine device can be safely scanned in a MR system with a static magnetic field up to 3 Tesla.

The signed Declaration of the manufacturer is available under section "Quality System".